Acute myeloid leukemia: open trials in Brazil

• NCT06852222

  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Fundacao Pio XII, Barretos · IDOR - Regional Brasilia, Brasília · Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba · Liga Norte Riograndense Contra o Cancer, Natal · Ministerio da Saude Instituto Nacional do Cancer, Rio de Janeiro · Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), Rio de Janeiro · IDOR - Regional Sao Paulo, São Paulo · Real e Benemerita Associacao Portuguesa de Beneficencia, São Paulo · Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo

  Registry updated 2026-11-03

• NCT05429632

  Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  Trial Treatment · Phase 3 · Priothera SAS

  Hospital Erasto Gaertner, Curicica · CEPON - Centro de Pesquisas Oncologicas, Florianópolis · Hospital Amaral Carvalho, São Paulo · Hospital Israelita Albert Einstein, São Paulo · Hospital Alemao Oswaldo Cruz (HAOC), São Paulo · Universidade de Sao Paulo (USP) - Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), São Paulo · Unicamp, São Paulo

  Registry updated 2026-10-30

• NCT07211958

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Trial Treatment · Phase 3 · Syndax Pharmaceuticals

  Barretos · Fortaleza · Jaú · Porto Alegre · São Paulo

  Registry updated 2026-10-21

• NCT06824168

  Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

  Trial Treatment · Phase 2 · Daiichi Sankyo

  Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba · Cetus Hospital Dia Oncologia, Minas Gerai · Hospital de Clinicas de Porto Alegre, Porto Alegre · Irmandade da Santa Casa de Misericórdia de Porto Alegre Centro Multidisciplinar de Pesquisa, Porto Alegre · INCA - Instituto Nacional de Câncer, Rio de Janeiro · "Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto CIP - Centro Integrado de Pesquisa", San Jose Rio Preto · Hospital Santa Marcelina, São Paulo · Icesp - Instituto Do Câncer Do Estado de São Paulo Octavio Frias de Oliveira, São Paulo

  Registry updated 2026-09-16

• NCT06982274

  Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

  Trial Treatment · Phase 2 · Instituto do Cancer do Estado de São Paulo

  Instituto do Câncer do Estado de São Paulo, São Paulo

  Registry updated 2025-05-30

• NCT06299462

  PTCy and ATG for MSD and MUD Transplants

  Trial Treatment · Phase 1/2 · Instituto Nacional de Cancer, Brazil

  Instituto Nacional de Câncer, Rio de Janeiro

  Registry updated 2025-02-25

• NCT06783478

  NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

  Trial Treatment · Phase 2 · Hospital de Clinicas de Porto Alegre

  Hospital de Clinicas de Porto Alegre, Porto Alegre

  Registry updated 2025-01-20

• NCT06537843

  Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia

  Trial Treatment · Phase 2 · Hospital Municipal São José

  Hospital Ophir Loyola, Belém · Hospital de Clínicas da UFPR, Curitiba · Hospital Universitario Polydoro Ernani de Sao Thiago, Florianópolis · Hospital Amaral Carvalho, Jaú · Hospital Municipal Sao Jose, Joinville

  Registry updated 2024-08-05

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error